ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded Anktiva® Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally - ImmunityBio
business 2026/02/23 17:18:38

ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded Anktiva® Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally - ImmunityBio

Source:Immunitybio.com
Author:jhollister

None

Related Articles

Ondas' 4M Defense Secures $30 Million Multi-Year Demining Program in Israel - Ondas Holdings
business 2026/02/09 13:33:39

Ondas' 4M Defense Secures $30 Million Multi-Year Demining Program in Israel - Ondas Holdings

None

Ondas.com
Read More
Stock futures are little changed as traders await big consumer inflation report: Live updates - CNBC
business 2026/02/12 23:23:00

Stock futures are little changed as traders await big consumer inflation report: Live updates - CNBC

Major U.S. averages dropped on Thursday as fears around artificial intelligence disruption spread …

CNBC
Read More
Goldman Traders Warn Stock Selling Isn’t Over in Choppy Market - bloomberg.com
business 2026/02/09 01:29:00

Goldman Traders Warn Stock Selling Isn’t Over in Choppy Market - bloomberg.com

After rebounding Friday to nearly erase a brutal mid-week slide, US stocks are facing more selling …

Bloomberg
Read More
Much ado about nothing? TikTok's U.S. usership steadies after turbulent start - CNBC
business 2026/02/16 03:27:00

Much ado about nothing? TikTok's U.S. usership steadies after turbulent start - CNBC

TikTok’s U.S. joint venture seems to have survived a turbulent rollout relatively unscathed, …

CNBC
Read More